Cancer Genetics

We believe that no two cancers or patients are the same. That’s why we offer personalised cancer testing through our collaboration with RGCC (Research Genetic Cancer Centre), a global leader in advanced cancer diagnostics.

Cancer is fundamentally a disease of diversity: every patient is unique, every cancer behaves differently, and every treatment should be tailored. RGCC tests use a simple blood sample to analyse cancer at the cellular and genetic level, providing detailed insights into how cancer may develop, respond to treatment, or return.

Type of RGCC Therapies

There is no one-size-fits-all approach to treating chronic disease. Every patient and their disease is different and they will respond to treatment in their own unique way. Below are 4 therapies RGCC offered:

Q-REstrain
Clavic-Q-RE
Vaccine Prep (ATA)
Dendritic cell therapy

Who Is It For?

Patients considering personalised or integrative cancer therapies
Cancer survivors wanting to monitor for recurrence

Benefits of RGCC Testing:

Detects circulating tumour cells (CTCs) and early cancer markers
Helps guide targeted, personalised treatment plans
Tracks cancer response over time for more informed decisions
Simple, non-invasive blood test – no surgery or radiation
Enhances survival rates and quality of life

Our mission is to support better outcomes, longer lives, and more empowered choices for those affected by cancer. Through this testing, we bring science, compassion, and precision medicine together — for care that truly fits you.